drugset / Trial / NCT06009874

Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI

NCT06009874

Recruiting 80 enrolled Mohammad Hussien Tantawy Soliman
RandomizedParallel-groupDouble-blindPrevention

Summary

This study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.

Timeline

Start
2023-10
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapagliflozin Small molecule 10 mg

Indications